Sponsor Dossier
Merz
Sponsor Dossier for Merz. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: XEOMIN,
- Device (sponsor): Belotero Revive - Dermal tissue reconstructive material, microbe-derived
- Device (sponsor): Radiesse Injectable Implant - Tissue reconstructive material, synthetic, fluid
- Device (sponsor): Belotero Balance Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Radiesse (+) Lidocaine - Dermal tissue reconstructive material, synthetic mineral, anaesthetic
- Device (sponsor): Belotero Lips Shape - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Belotero Soft Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Belotero Lips Contour - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Belotero Volume Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Belotero Intense Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Ultrasonic body-contouring system
- Device (sponsor): Transducer assembly, ultrasound, therapeutic, hyperthermia, extracorporeal
About
Merz is an Australian Private Company with ABN 62151073559, registered in NSW and currently active. The company operates under the trading name Merz Aesthetics.
Portfolio
Merz has one brand on the ARTG, with one indexable brand cleared for search visibility. The portfolio includes one brand with Product Information on file, one brand with PBAC outcome(s), and one brand with AusPAR(s). No brands are currently PBS-listed.
Therapeutic focus
— Neurology: 1 brand
Regulatory activity
Merz has one brand with PBAC outcomes on record, with the most recent outcome dated 1 July 2025. One brand holds an AusPAR, with the most recent registration dated 17 March 2014.